OBJECTIVES: Hepatocellular carcinoma (HCC) is the primary liver cancer and second leading cause of cancer related
deaths worldwide. The aim of this present study was to evaluate the biochemical, histopathological and
chemotherapeutic efcacy of p-methoxycinnamic acid (p-MCA) against N- nitrosodiethylamine (NDEA) in a rat model of hepatocellular
carcinoma. MATERIALS AND METHODS: Approximately thirty male wistar rats weighing 150-200 g were designated for this study. The
rats were arbitrarily separated into ve groups and each group comprised of six rats. Group 1 served as control; Group 2 rats received p-MCA at
the dose of 80 mg/kg b.w. Group 3, 4 and 5 rats were induced HCC using NDEA. 2-acetylaminouorene (AAF) was used as a promotor. Group 4
and 5 rats received p-MCA at the doses of 40 and 80 mg/kg b.w. throughout the 12 week experimental period. At the end of the experimental
period, liver tissues from all the rats were collected and liver specic enzymes, lipid peroxidation, markers, xenobiotic metabolizing enzymes,
antioxidant status and brotic markers were evaluated.RESULTS: NDEA administration induced hepatocyte damage, oxidative stress, cell
proliferation, inammation and brosis. The liver sections from NDEA induced group 3 rats showed loss of lobular architecture, morphological
changes in the nuclei and DNA damage. Administration of p-MCA to NDEA treated rats restored the hepatic architecture, enzyme activities, cell
proliferation, inammation and brosis.CONCLUSION: We conclude that oral administration of p-MCA for 12 weeks exerts a signicant
therapeutic effect against HCC by regulating the concentration of specic hepatic and xenobiotic enzymes, suppressing oxidative stress,
inhibiting cell proliferation and reducing the inammatory response.